Mosholder AD - Search Results

1

Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.

Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R. Mosholder AD, et al. Pediatrics. 2009 Feb;123(2):611-6. doi: 10.1542/peds.2008-0185. Pediatrics. 2009. PMID: 19171629 Review.

2

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.

Phelan KM, Mosholder AD, Lu S. Phelan KM, et al. Among authors: mosholder ad. J Clin Psychiatry. 2003 Nov;64(11):1328-34. doi: 10.4088/jcp.v64n1108. J Clin Psychiatry. 2003. PMID: 14658947 Review.

3

Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.

Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M. Brinker A, et al. J Child Adolesc Psychopharmacol. 2007 Jun;17(3):328-33. doi: 10.1089/cap.2006.0062. J Child Adolesc Psychopharmacol. 2007. PMID: 17630866

4

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.

Colman E, Szarfman A, Wyeth J, Mosholder A, Jillapalli D, Levine J, Avigan M. Colman E, et al. Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1068-76. doi: 10.1002/pds.1643. Pharmacoepidemiol Drug Saf. 2008. PMID: 18821724

5

Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.

Gish P, Mosholder AD, Truffa M, Johann-Liang R. Gish P, et al. Among authors: mosholder ad. J Pediatr. 2009 Sep;155(3):432-4. doi: 10.1016/j.jpeds.2009.01.074. J Pediatr. 2009. PMID: 19732583

6

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, Mosholder AD. Pamer CA, et al. Among authors: mosholder ad. Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):158-74. doi: 10.1002/pds.1886. Pharmacoepidemiol Drug Saf. 2010. PMID: 20049836

7

Suicide and antidepressants. Beware extrapolation from ecological data.

Hammad TA, Mosholder AD. Hammad TA, et al. Among authors: mosholder ad. BMJ. 2010 Nov 30;341:c6844. doi: 10.1136/bmj.c6844. BMJ. 2010. PMID: 21118884 No abstract available.

8

Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.

McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D. McMahon AW, et al. Among authors: mosholder ad. Pediatrics. 2011 Nov;128(5):e1147-54. doi: 10.1542/peds.2010-1720. Epub 2011 Oct 24. Pediatrics. 2011. PMID: 22025595 Review.

9

Antidepressant medication dispensing among montelukast initiators.

Zhou EH, Kaplan S, Mosholder A, Moeny D, Ding Y, Wu Y, Iyasu S, Hammad TA. Zhou EH, et al. J Asthma. 2013 Nov;50(9):990-5. doi: 10.3109/02770903.2013.823445. Epub 2013 Aug 20. J Asthma. 2013. PMID: 23841530

10

Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).

Mosholder AD, Kim J, Davis M, Farchione TR. Mosholder AD, et al. J Child Adolesc Psychopharmacol. 2019 Nov;29(9):725. doi: 10.1089/cap.2019.0061. Epub 2019 May 16. J Child Adolesc Psychopharmacol. 2019. PMID: 31094581 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters